HMS-BIDMC, Alnylam Pharmaceuticals
Cambridge, Massachusetts, United States
Disclosure information not submitted.
SAT-193 - AKR1C3 silencing in adipose lowers circulating androgens: potential implications for PCOS
Saturday, June 13, 2026
9:30 AM - 4:30 PM CT